跳至主要内容
临床试验/EUCTR2008-004497-40-GB
EUCTR2008-004497-40-GB进行中(未招募)1 期

The effect of metformin on weight and cardiovascular risk markers in abdomenally obese subjects with impaired fasting glucose previously treated for 12 months with either rimonabant or placebo - Use of Metformin following weight loss and improvement in CV risk

Hull and East Yorkshire Hospitals NHS Trust0 个研究点目标入组 0 人开始时间: 2008年10月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Previous participation in RIMON_R_00961
  • Impaired fasting glucose
  • LFT less than 200% reference range
  • Serum Creatinine less than 150 mmol/l
  • Willing to allow GP to be informed
  • Able to give consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Not having previously been diagnosed with diabetes
  • Previously been treated with antidiabetes medication
  • Not able to give consent or allow GP to be informed

研究者

发起方
Hull and East Yorkshire Hospitals NHS Trust

相似试验